Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: Reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 367-374

  O'Regan, Edel ^a   Quinn, Teresa ^a   Frye, Jonathan G ^b   Pagés, Jean Marie ^c   Porwollik, Steffen ^d   Fedorka Cray, Paula J ^b   McClelland, Michael ^d   Fanning, Séamus ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c Aix Marseille University   (France)

^d Vaccine Research Institute of San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LIPOPOLYSACCHARIDE; PORIN; PROTEIN PARC;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM MUTANT; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENVIRONMENTAL STRESS; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; MARA BACTERIAL GENE; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY ISLAND; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEROTYPE; SOXR BACTERIAL GENE; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; CACO-2 CELLS; CIPROFLOXACIN; CONJUGATION, GENETIC; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PORINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS;

EID: 73849130552     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00801-09     Document Type: Article

References (47)

1. Alonso, A., G. Morales, R. Escalante, E. Campanario, L. Sastre, and J. L. Martinez. 2004. Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J. Antimicrob. Chemother. 53:432-434.
2. Andersson, D. I. 2006. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol. 9:461-465.
3. Bagel, S., V. Hullen, B. Wiedemann, and P. Heisig. 1999. Impact of GyrA and ParC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob. Agents Chemother. 43:868-875.
4. Baxter, M. A., and B. D. Jones. 2005. The fimYZ genes regulate Salmonella enterica serovar Typhimurium invasion in addition to type 1 fimbrial expression and bacterial motility. Infect. Immun. 73:1377-1385.
5. Carrique-Mas, J. J., C. Papadopoulou, S. J. Evans, A. Wales, C. J. Teale, and R. H. Davies. 2008. Trends in phage types and antimicrobial resistance of Salmonella enterica serovar Enteritidis isolated from animals in Great Britain from 1990 to 2005. Vet. Rec. 162:541-546.
6. CDC. 2007. One-day (24-48 h) standardized laboratory protocol for molecular subtyping of Escherichia coli O157:H7, non-typhoidal Salmonella sero-types, and Shigella sonnei by pulsed field gel electrophoresis (PFGE). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov /pulsenet/protocols/ecoli-salmonella-shigella-protocols.pdf.
7. Chan, Y. Y., H. S. Bian, T. M. Tan, M. E. Mattmann, G. D. Geske, J. Igarashi, T. Hatano, H. Suga, H. E. Blackwell, and K. L. Chua. 2007. Control of quorum sensing by a Burkholderia pseudomallei multidrug efflux pump. J. Bacteriol. 189:4320-4324.
8. Chander, M., L. Raducha-Grace, and B. Demple. 2003. Transcription-defective soxR mutants of Escherichia coli: isolation and in vivo characterization. J. Bacteriol. 185:2441-2450.
9. Chiu, C. H., T. L. Wu, L. H. Su, C. Chu, J. H. Chia, A. J. Kuo, M. S. Chien, and T. Y. Lin. 2002. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N. Engl. J. Med. 346:413-419.
10. Choi, J., D. Shin, and S. Ryu. 2007. Implication of quorum sensing in Salmonella enterica serovar Typhimurium virulence: the luxS gene is necessary for expression of genes in pathogenicity island 1. Infect. Immun. 75: 4885-4890.
11. CLSI/NCCLS. 2004. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S14. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Crump, J. A., T. J. Barrett, J. T. Nelson, and F. J. Angulo. 2003. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin. Infect. Dis. 37:75-81.
13. Dorman, C. J., and C. P. Corcoran. 2009. Bacterial DNA topology and infectious disease. Nucleic Acids Res. 37:672-678.
14. Dowd, S. E., K. Killinger-Mann, M. Brashears, and J. Fralick. 2008. Evaluation of gene expression in a single antibiotic exposure-derived isolate of Salmonella enterica typhimurium 14028 possessing resistance to multiple antibiotics. Foodborne Pathog. Dis. 5:205-221.
15. Drlica, K., and X. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
16. Frost, J. A., A. Kelleher, and B. Rowe. 1996. Increasing ciprofloxacin resistance in Salmonella in England and Wales 1991-1994. J. Antimicrob. Chemother. 37:85-91.
17. Giraud, E., S. Baucheron, and A. Cloeckaert. 2006. Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes Infect. 8:1937-1944.
18. Giraud, E., A. Cloeckaert, S. Baucheron, C. Mouline, and E. Chaslus-Dancla. 2003. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J. Med. Microbiol. 52:697-703.
19. Giraud, E., A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla. 2000. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium. Antimicrob. Agents Chemother. 44:1223-1228.
20. Hopkins, K. L., R. H. Davies, and E. J. Threlfall. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents 25:358-373.
21. Ibarra, J. A., and O. Steele-Mortimer. 2009. Salmonella-the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell. Microbiol. 11:1579-1586.
22. Izumiya, H., K. Mori, T. Kurazono, M. Yamaguchi, M. Higashide, N. Konishi, A. Kai, K. Morita, J. Terajima, and H. Watanabe. 2005. Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan. J. Clin. Microbiol. 43:5074-5079.
23. Kugelberg, E., S. Lofmark, B. Wretlind, and D. I. Andersson. 2005. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 55:22-30.
24. La Ragione, R. M., W. A. Cooley, P. Velge, M. A. Jepson, and M. J. Woodward. 2003. Membrane ruffling and invasion of human and avian cell lines is reduced for aflagellate mutants of Salmonella enterica serotype Enteritidis. Int. J. Med. Microbiol. 293:261-272.
25. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
26. Meakins, S., I. S. Fisher, C. Berghold, P. Gerner-Smidt, H. Tschape, M. Cormican, I. Luzzi, F. Schneider, W. Wannett, J. Coia, A. Echeita, and E. J. Threlfall. 2008. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: a report from the Enter-net International Surveillance Network. Microb. Drug Resist. 14:31-35.
27. Miro, E., C. Verges, I. Garcia, B. Mirelis, F. Navarro, P. Coll, G. Prats, and L. Martinez-Martinez. 2004. Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system. Enferm. Infecc. Microbiol. Clin. 22:204-211. (In Spanish.)
28. Molbak, K., D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gerner-Smidt, A. M. Petersen, and H. C. Wegener. 1999. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N. Engl. J. Med. 341:1420-1425.
29. Molbak, K., P. Gerner-Smidt, and H. C. Wegener. 2002. Increasing quino-lone resistance in Salmonella enterica serotype Enteritidis. Emerg. Infect. Dis. 8:514-515.
30. Nikaido, H. 1998. Multiple antibiotic resistance and efflux. Curr. Opin. Microbiol. 1:516-523.
31. Olsen, S. J., E. E. DeBess, T. E. McGivern, N. Marano, T. Eby, S. Mauvais, V. K. Balan, G. Zirnstein, P. R. Cieslak, and F. J. Angulo. 2001. A nosocomial outbreak of fluoroquinolone-resistant Salmonella infection. N. Engl. J. Med. 344:1572-1579.
32. O'Regan, E., T. Quinn, J. M. Pages, M. McCusker, L. Piddock, and S. Fanning. 2009. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar Enteritidis: involvement of RamA and other global regulators. Antimicrob. Agents Chemother. 53:1080-1087.
33. Pearson, J. P., C. Van Delden, and B. H. Iglewski. 1999. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181:1203-1210.
34. Piddock, L. J., D. J. Griggs, M. C. Hall, and Y. F. Jin. 1993. Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob. Agents Chemother. 37:662-666.
35. Piddock, L. J., V. Ricci, I. McLaren, and D. J. Griggs. 1998. Role of mutation in the gyrA and parC genes of nalidixic-acid- resistant Salmonella serotypes isolated from animals in the United Kingdom. J. Antimicrob. Chemother. 41:635-641.
36. Pomposiello, P. J., and B. Demple. 2000. Identification of soxS-regulated genes in Salmonella enterica serovar Typhimurium. J. Bacteriol. 182:23-29.
37. Ramos, J. L., and R. C. Levesque. 2006. Pseudomonas: molecular biology of emerging issues, vol. 4. Springer, Berlin, Germany.
38. Randall, L. P., and M. J. Woodward. 2002. The multiple antibiotic resistance (mar) locus and its significance. Res. Vet. Sci. 72:87-93.
39. Sanchez, P., J. F. Linares, B. Ruiz-Diez, E. Campanario, A. Navas, F. Baquero, and J. L. Martinez. 2002. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J. Antimicrob. Chemother. 50:657-664.
40. Simonet, V., M. Mallea, D. Fourel, J. M. Bolla, and J. M. Pages. 1996. Crucial domains are conserved in Enterobacteriaceae porins. FEMS Microbiol. Lett. 136:91-97.
41. Sperandio, V., A. G. Torres, and J. B. Kaper. 2002. Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol. Microbiol. 43:809-821.
42. Stevenson, J. E., K. Gay, T. J. Barrett, F. Medalla, T. M. Chiller, and F. J. Angulo. 2007. Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. Antimicrob. Agents Chemother. 51:195-197.
43. Thiagarajan, D., A. M. Saeed, and E. K. Asem. 1994. Mechanism of transovarian transmission of Salmonella Enteritidis in laying hens. Poult. Sci. 73: 89-98.
44. Vasallo, F. J., P. Martin-Rabadan, L. Alcala, J. M. Garcia-Lechuz, M. Rodriguez-Creixems, and E. Bouza. 1998. Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin. Infect. Dis. 26:535-536.
45. Wang, Y. P., L. Li, J. Z. Shen, F. J. Yang, and Y. N. Wu. 2009. Quinolone-resistance in Salmonella is associated with decreased mRNA expression of virulence genes invA and avrA, growth and intracellular invasion and survival. Vet. Microbiol. 133:328-334.
46. Xia, X., M. McClelland, and Y. Wang. 2005. WebArray: an online platform for microarray data analysis. BMC Bioinformatics 6:306.
47. Zhang, Q., O. Sahin, P. F. McDermott, and S. Payot. 2006. Fitness of antimicrobial-resistant Campylobacter and Salmonella. Microbes Infect. 8:1972-1978.